Verge Genomics

ALS neurons brain synapses

Biotech

Ferrer offers $122M biobucks for ex-US license to Verge ALS drug

Spanish pharma Ferrer is following in Big Pharma’s footsteps by targeting the AI-powered neuroscience R&D work of Verge Genomics.

James Waldron Mar 25, 2024 8:16am

merge MA railway train tracks path together

AstraZeneca converges with Verge's AI tech in $42M R&D pact

Sep 8, 2023 7:00am

parachutes ladders

Roche taps new North American diagnostics chief—Chutes & Ladders

Dec 9, 2022 9:30am

Parachute

Ayala, Advaxis merger means new leadership team—Chutes & Ladders

Oct 21, 2022 9:30am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am

image of AI

Verge Genomics signs on Merck, Lilly for nearly $100M funding

Dec 16, 2021 6:30am